XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (loss) Income
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2018 $ 16,746   $ 2,266 $ 2 $ (15,554) $ (13,286)
Balance at beginning of period (shares) at Dec. 31, 2018 4,801,020 5,166,812        
Increase (Decrease) in Stockholders' Equity            
Stock–based compensation     60     60
Foreign currency translation adjustment       (2)   (2)
Net loss         (2,464) (2,464)
Balance at end of period at Mar. 31, 2019 $ 16,746   2,326   (18,018) (15,692)
Balance at end of period (shares) at Mar. 31, 2019 4,801,020 5,166,812        
Balance at beginning of period at Dec. 31, 2018 $ 16,746   2,266 2 (15,554) (13,286)
Balance at beginning of period (shares) at Dec. 31, 2018 4,801,020 5,166,812        
Increase (Decrease) in Stockholders' Equity            
Net loss           (7,986)
Balance at end of period at Sep. 30, 2019 $ 40,912   2,459   (23,540) (21,081)
Balance at end of period (shares) at Sep. 30, 2019 8,264,613 5,166,812        
Balance at beginning of period at Mar. 31, 2019 $ 16,746   2,326   (18,018) (15,692)
Balance at beginning of period (shares) at Mar. 31, 2019 4,801,020 5,166,812        
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock in exchange for process research and development $ 24,166          
Issuance of common stock in exchange for process research and development (in shares) 3,463,593          
Stock–based compensation     79     79
Foreign currency translation adjustment       11   11
Net loss         (1,901) (1,901)
Balance at end of period at Jun. 30, 2019 $ 40,912   2,405 11 (19,919) (17,503)
Balance at end of period (shares) at Jun. 30, 2019 8,264,613 5,166,812        
Increase (Decrease) in Stockholders' Equity            
Stock–based compensation     54     54
Foreign currency translation adjustment       (11)   (11)
Net loss         (3,621) (3,621)
Balance at end of period at Sep. 30, 2019 $ 40,912   2,459   (23,540) (21,081)
Balance at end of period (shares) at Sep. 30, 2019 8,264,613 5,166,812        
Balance at beginning of period at Dec. 31, 2019   $ 16 49,130 12 (36,866) 12,292
Balance at beginning of period (shares) at Dec. 31, 2019   15,592,718        
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options     53     53
Exercise of stock options (in shares)   84,589        
Stock–based compensation     159     159
Foreign currency translation adjustment       (34)   (34)
Net loss         (4,730) (4,730)
Balance at end of period at Mar. 31, 2020   $ 16 49,342 (22) (41,596) 7,740
Balance at end of period (shares) at Mar. 31, 2020   15,677,307        
Balance at beginning of period at Dec. 31, 2019   $ 16 49,130 12 (36,866) $ 12,292
Balance at beginning of period (shares) at Dec. 31, 2019   15,592,718        
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options (in shares)           84,589
Net loss           $ (10,168)
Balance at end of period at Sep. 30, 2020   $ 17 56,526 (3) (47,034) 9,506
Balance at end of period (shares) at Sep. 30, 2020   16,427,307        
Balance at beginning of period at Mar. 31, 2020   $ 16 49,342 (22) (41,596) 7,740
Balance at beginning of period (shares) at Mar. 31, 2020   15,677,307        
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock in connection with equity financing   $ 1 7,499     7,500
Issuance of common stock in connection with equity financing (in shares)   750,000        
Transaction costs in connection with equity financing     (984)     (984)
Stock–based compensation     171     171
Issuance of broker warrants in connection with equity financing     289     289
Foreign currency translation adjustment       6   6
Net loss         (2,384) (2,384)
Balance at end of period at Jun. 30, 2020   $ 17 56,317 (16) (43,980) 12,338
Balance at end of period (shares) at Jun. 30, 2020   16,427,307        
Increase (Decrease) in Stockholders' Equity            
Stock–based compensation     209     209
Foreign currency translation adjustment       13   13
Net loss         (3,054) (3,054)
Balance at end of period at Sep. 30, 2020   $ 17 $ 56,526 $ (3) $ (47,034) $ 9,506
Balance at end of period (shares) at Sep. 30, 2020   16,427,307